Johnson & Johnson Agrees to Settlement Over Alleged Deception in Hip Implant Marketing


Bloomberg News reports that Johnson & Johnson has agreed to pay Oregon $4 million to “resolve deceptive marketing claims over recalled metal-on-metal hip implants,” thereby marking the company’s “first accord with any governmental unit involving the devices.” The company has recalled 93,000 ASR hip implants worldwide, citing a 12% failure rate in five years. Bloomberg News further reports that the U.S. Justice Department and the U.S. Attorney’s Office in Massachusetts “are probing whether the company made false claims or false statements about the devices to federal health care programs.”

From the news release of the American Association for Justice.

This entry was posted in Medical & Health Resources or Issues. Bookmark the permalink.

Comments are closed.